TRIM35 Negatively Regulates the cGAS-STING-Mediated Signaling Pathway by Attenuating K63-Linked Ubiquitination of STING
Related Experiment Video
Updated: Jun 18, 2025

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli
Published on: December 26, 2020
Jikai Zhang1,2, Yuhao Wu1, Yiwen Wang1
1Xuzhou Medical University, Xuzhou, China.
Abstract:
The cGAS-STING-mediated antiviral response plays an important role in the defense against DNA virus infection. Tripartite motif protein 35 (TRIM35), an E3 ubiquitin ligase, was identified as a positive regulator of RLR-mediated antiviral signaling in our previous study, but the effect of TRIM35 on the cGAS-STING signaling pathway has not been elucidated. Herein, we showed that TRIM35 negatively regulates the cGAS-STING signaling pathway by directly targeting STING. TRIM35 overexpression significantly inhibited the cGAMP-triggered phosphorylation of TBK1 and IRF3, attenuating IFN-β expression and the downstream antiviral response. Mechanistically, TRIM35 colocalized and directly interacted with STING in the cytoplasm. TRM35 removed K63-linked ubiquitin from STING through the C36 and C44 sites in the RING domain, which impaired the interaction of STING with TBK1 or IKKε. In addition, we demonstrated that the RING domain is a key region for the antiviral effects of TIRM35. These results collectively indicate that TRIM35 negatively regulates type I interferon (IFN-I) production by targeting and deubiquitinating STING. TRIM35 may be a potential therapeutic target for controlling viral infection.
Insights
Tripartite motif protein 35 (TRIM35) negatively regulates the cGAS-STING antiviral pathway. TRIM35 deubiquitinates STING, inhibiting type I interferon production and viral defense.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for antiviral immunity against DNA viruses.
- Tripartite motif protein 35 (TRIM35) is known to positively regulate retinoic acid-inducible gene I (RIG-I)-like receptor (RLR) signaling.
- The role of TRIM35 in the cGAS-STING pathway remained unclear.
Purpose of the Study:
- To investigate the function of TRIM35 in the cGAS-STING signaling pathway.
- To elucidate the mechanism by which TRIM35 affects cGAS-STING-mediated antiviral responses.
Main Methods:
- Co-immunoprecipitation assays to confirm TRIM35 and STING interaction.
- Western blotting to detect phosphorylation of TBK1 and IRF3.
- Interferon-beta (IFN-β) reporter assays.
- Site-directed mutagenesis of TRIM35's RING domain.
Main Results:
- TRIM35 negatively regulates the cGAS-STING pathway by directly interacting with STING.
- TRIM35 overexpression inhibited cGAMP-induced phosphorylation of TBK1 and IRF3, reducing IFN-β production.
- TRIM35 deubiquitinates STING at K63-linked ubiquitin chains, impairing STING's interaction with TBK1/IKKε.
- The RING domain of TRIM35 is essential for its antiviral activity.
Conclusions:
- TRIM35 acts as a negative regulator of the cGAS-STING pathway.
- TRIM35 inhibits type I interferon (IFN-I) production by deubiquitinating STING.
- TRIM35 represents a potential therapeutic target for managing viral infections.
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
Amplifying Signals via Enzymatic Cascade
GPCRs Regulate Adenylyl Cylase Activity
Activation and Inactivation of G Proteins
GPCR Desensitization

